Revolutionary research shows statins combined with new PIN1 inhibitors could transform bladder cancer treatment, offering hope to thousands of patients.
ImmunityBio is at the forefront of developing innovative immunotherapies and cell therapies. The company has a vertically integrated approach, allowing it to oversee every step of development, from ...